MONTREAL, Jan. 17 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. is pleased to announce that its leading edge proprietary product, Neptune Krill Oil (NKO(TM)) is now being distributed in 12 countries around the world, and will, during the current year, be launched in most of the 39 countries that Pharmanex, a division of NuSkin Enterprises, well known for its "NuSkin(TM) brands", operates in.
"The deal with Pharmanex is strategically very important; it went efficiently through a very rigorous process and Neptune will definitely benefit from it. Pharmanex is one of the largest MLM Corporations and is now aggressively penetrating new countries with NKO(TM)" said Tina Sampalis, M.D., Ph.D. Vice President, Research / Business & Development, at Neptune Technologies & Bioressources Inc. "Moreover, being 1 of only 3 authorized MLM Companies to operate in China; we are looking forward for Pharmanex to bring NKO(TM) to China, as well. This is very exciting and promising for Neptune," added Dr. Sampalis.
Neptune Technologies & Bioressources Inc. develops and exploits marine biomasses with its patented extraction process (Neptune OceanExtract(TM)) utilizing marine biomasses, such as krill, and due to its technologies, Neptune Technologies & Bioressources Inc., is strategically well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004).
Neptune Technologies & Bioressources Inc. is listed on the following Stock Exchange Market TSX-V Venture Exchange under the ticker symbol NTB.V, Berlin Exchange under the ticker symbol NTB.BE and the U.S Pink Sheets Exchange under the ticker symbol NPTZF.PK.